Results
Revise Search
-
Filters:
- All Records
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- 1987
- 2009
Adverse reactions between alcohol and drug products
https://policybase.cma.ca/en/permalink/policy805
- Last Reviewed
- 2017-03-04
- Date
- 1987-08-25
- Topics
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Resolution
- GC87-31
- That the Canadian Medical Association urge appropriate agencies to adopt regulations and/or policies to ensure that warnings about the adverse interaction between alcohol and both prescription and non-prescription products be prominently displayed or distributed wherever alcohol and drugs are sold and/or dispensed.
- Policy Type
- Policy resolution
- Last Reviewed
- 2017-03-04
- Date
- 1987-08-25
- Resolution
- GC87-31
- That the Canadian Medical Association urge appropriate agencies to adopt regulations and/or policies to ensure that warnings about the adverse interaction between alcohol and both prescription and non-prescription products be prominently displayed or distributed wherever alcohol and drugs are sold and/or dispensed.
- Text
- That the Canadian Medical Association urge appropriate agencies to adopt regulations and/or policies to ensure that warnings about the adverse interaction between alcohol and both prescription and non-prescription products be prominently displayed or distributed wherever alcohol and drugs are sold and/or dispensed.
Drug product substitution
https://policybase.cma.ca/en/permalink/policy806
- Last Reviewed
- 2017-03-04
- Date
- 1987-08-25
- Topics
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Resolution
- GC87-39
- The Canadian Medical Association supports the position that: 1) a patient should have the right to choose either a generic or a brand-name prescription drug where both alternatives exist; and 2) a physician should have the right to order "no substitution" of a drug product he or she prescribes.
- Policy Type
- Policy resolution
- Last Reviewed
- 2017-03-04
- Date
- 1987-08-25
- Resolution
- GC87-39
- The Canadian Medical Association supports the position that: 1) a patient should have the right to choose either a generic or a brand-name prescription drug where both alternatives exist; and 2) a physician should have the right to order "no substitution" of a drug product he or she prescribes.
- Text
- The Canadian Medical Association supports the position that: 1) a patient should have the right to choose either a generic or a brand-name prescription drug where both alternatives exist; and 2) a physician should have the right to order "no substitution" of a drug product he or she prescribes.
Training and support for physicians in addiction medicine
https://policybase.cma.ca/en/permalink/policy9524
- Last Reviewed
- 2016-05-20
- Date
- 2009-08-19
- Topics
- Health human resources
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Ethics and medical professionalism
- Resolution
- GC09-78
- The Canadian Medical Association calls on national and provincial/territorial medical education and licensing bodies to expand training and support for physicians in addiction medicine, including formal recognition of special skills and improved training and support opportunities for primary care physicians.
- Policy Type
- Policy resolution
- Last Reviewed
- 2016-05-20
- Date
- 2009-08-19
- Topics
- Health human resources
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Ethics and medical professionalism
- Resolution
- GC09-78
- The Canadian Medical Association calls on national and provincial/territorial medical education and licensing bodies to expand training and support for physicians in addiction medicine, including formal recognition of special skills and improved training and support opportunities for primary care physicians.
- Text
- The Canadian Medical Association calls on national and provincial/territorial medical education and licensing bodies to expand training and support for physicians in addiction medicine, including formal recognition of special skills and improved training and support opportunities for primary care physicians.
E-prescribing
https://policybase.cma.ca/en/permalink/policy9538
- Last Reviewed
- 2016-05-20
- Date
- 2009-08-19
- Topics
- Health systems, system funding and performance
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Resolution
- GC09-42
- The Canadian Medical Association and provincial/territorial medical associations will work with governments to accelerate the introduction of e-prescribing in Canada to make it the main method of prescribing by 2012.
- Policy Type
- Policy resolution
- Last Reviewed
- 2016-05-20
- Date
- 2009-08-19
- Topics
- Health systems, system funding and performance
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Resolution
- GC09-42
- The Canadian Medical Association and provincial/territorial medical associations will work with governments to accelerate the introduction of e-prescribing in Canada to make it the main method of prescribing by 2012.
- Text
- The Canadian Medical Association and provincial/territorial medical associations will work with governments to accelerate the introduction of e-prescribing in Canada to make it the main method of prescribing by 2012.